Back
Neumora Therapeutics 10K Form
Sell
26
NMRA
Neumora Therapeutics
Last Price:
10.33
Seasonality Move:
43.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NMRA News And Ratings
See the #1 stock for the next 7 days that we like better than NMRA
NMRA Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-33.48M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.00 |
| Price / Book: | 5.33 |
Profitability
| EPS (TTM): | -1.84460 |
|---|---|
| Net Income (TTM): | $-293.7M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Neumora Therapeutics Earnings Forecast
Key Neumora Therapeutics Financial Ratios
- Per Share Earnings over the last 4 years have been positive in 1 years.
Neumora Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NMRA |
| Website: | neumoratx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NMRA Technical Analysis vs Fundamental Analysis
Sell
26
Neumora Therapeutics (NMRA)
is a Sell
Is Neumora Therapeutics a Buy or a Sell?
-
Neumora Therapeutics stock is rated a Sell
The current Neumora Therapeutics [NMRA] share price is $10.32. The Score for NMRA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.